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ARTICLE
Family-Based Association Tests for Genomewide Association Scans
Wei-Min Chen and Gonc¸alo R. Abecasis
With millions of single-nucleotide polymorphisms (SNPs) identified and characterized, genomewide association studies
have begun to identify susceptibility genes for complex traits and diseases. These studies involve the characterization
and analysis of very-high-resolution SNP genotype data for hundreds or thousands of individuals. We describe a com-
putationally efficient approach to testing association between SNPs and quantitative phenotypes, which can be applied
to whole-genome association scans. In addition to observed genotypes, our approach allows estimation of missing
genotypes, resulting in substantial increases in power when genotyping resources are limited. We estimate missing
genotypes probabilistically using the Lander-Green or Elston-Stewart algorithms and combine high-resolution SNP ge-
notypes for a subset of individuals in each pedigree with sparser marker data for the remaining individuals. We show
that power is increased whenever phenotype information for ungenotyped individuals is included in analyses and that
high-density genotyping of just three carefully selected individuals in a nuclear family can recover 190% of the infor-
mation available if every individual were genotyped, for a fraction of the cost and experimental effort. To aid in study
design, we evaluate the power of strategies that genotype different subsets of individuals in each pedigree and make
recommendations about which individuals should be genotyped at a high density. To illustrate our method, we performed
genomewide association analysis for 27 gene-expression phenotypes in 3-generation families (Centre d’Etude du Poly-
morphisme Humain pedigrees), in which genotypes for ∼860,000 SNPs in 90 grandparents and parents are complemented
by genotypes for ∼6,700 SNPs in a total of 168 individuals. In addition to increasing the evidence of association at 15
previously identified cis-acting associated alleles, our genotype-inference algorithm allowed us to identify associated
alleles at 4 cis-acting loci that were missed when analysis was restricted to individuals with the high-density SNP data.
Our genotype-inference algorithm and the proposed association tests are implemented in software that is available for
free.
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Rapid advances in genotyping technology and the avail-
ability of very large inventories of SNPs are making new
strategies for genetic mapping possible.1–3 It is now prac-
tical to examine hundreds of thousands of SNPs, repre-
senting a large fraction of the common variants in the
human genome,4,5 in very large numbers of individuals.
Genetic association studies, which traditionally focused
on relatively small numbers of SNPs within candidate
genes or regions, can now be performed on a genomic
scale.
These technological advances, which are revolutioniz-
ing human genetics, will greatly impact analytical strat-
egies for family-based association studies. For example,
some of the most popular techniques for association anal-
ysis of family data are the transmission/disequilibriumtest
and its extensions,6–10 which focus on the transmission of
alleles from heterozygous parents to their offspring. The
strategy results in association tests that are robust to pop-
ulation stratification, even when a single marker is ex-
amined, at the cost of a substantial loss in power on a per-
genotype basis.11,12 Loss of power occurs because these
methods rely on a single marker to simultaneouslyprovide
evidence of association and guard against population
stratification. When genotype data are available on a ge-
nomic scale, methods that use multiple markers to eval-
uate the effects of population structure, such as genomic
control13 or structured association mapping,14 are likely to
provide a more cost-effective way to guard against pop-
ulation stratification. Thus, as association studies per-
formed on a genomic scale become the norm, we expect
that association tests that focus on allelic transmission
from heterozygous parents will be replaced by tests that
use genomic data to control for stratification.
Another feature that we expect will become important
in association tests in the future is the ability to incor-
porate phenotypes of relatives that are not directly mea-
sured for the marker of interest when evidence of asso-
ciation is evaluated.15–17 Since related individuals share a
large fraction of their genetic material, genotypes for one
or more individuals in a family can be used to estimate
genotypes of their relatives. If flanking-marker data are
available, missing genotypes often can be imputed with
very high accuracy, and the imputed genotypes provide
substantial gains in power.15 However, even without flank-
ing-marker data, genotypes of relatives can be estimated
and used to increase the power of genetic association stud-
ies.17 Unfortunately, most of the currently available fam-
ily-based association tests consider only the phenotypes
of individuals for whom genotype data are available.
Here, we describe two efficient approaches to testing for
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association between a genetic marker and a quantitative
trait that incorporate phenotype information for relatives
and that readily allow genomic data to be used to control
for stratification. In one approach, evidence of association
is evaluated within a computationally demanding maxi-
mum-likelihood framework. In another approach, evi-
dence of association is evaluated using a rapid score test
that substantially reduces computational time at the ex-
pense of a slight loss of power. When evidence of asso-
ciation at a genetic marker is evaluated, both approaches
not only examine individuals for whom genotype and
phenotype data are available, but also examine the phe-
notypes of their relatives, if available. In addition, both
approaches can use genotype data at flanking markers to
improve estimates of unobserved genotypes and to further
increase power. The proposed approaches do not focus on
alleles transmitted from heterozygous parents. Instead, to
control for stratification in admixed samples, they rely on
estimates of the ancestry of each individual to be provided
as covariates. These estimates can be computed from ge-
nomic data.14,18 Our approaches can accommodate many
distinct pedigree configurations (each with potentially dif-
ferent subsets of genotyped and phenotyped individuals),
and, in the “Results” section, we illustrate some of the
possibilities through the analysis of simulated and real
data sets.
Methods
Definitions
We consider a phenotype of interest, measured in a set of pedi-
grees, each including one or more related individuals. We let Yij
and denote the observed trait and covariates, respectively, forxij
individual j in family i. Similarly, we let denote the observedGijm
genotype at marker m for individual j in family i. Different
amounts of data may be available or missing for each individual.
For example, for some individuals, both phenotype and genotype
data may be available; for others, only phenotype data or only
genotype data may be available; and, for yet others, neither may
be available. Further note that, in each individual for whom ge-
notype data are available, genotypes may be available for only a
subset of markers.
Model for Association
For each of the genotyped SNP markers, we are interested in test-
ing whether observed genotypes and phenotypes are associated.
For the SNP being tested, we label the two alleles “A” and “a”
and define a genotype score, , as 0, 1, or 2, depending ongijm
whether , A/a, or A/A, respectively. To avoid unneces-G p a/aijm
sary cumbersome notation, and because we evaluate the evidence
of association one SNP at a time, we drop the index m in our
presentation below. We consider the model
E(Y )p m b g  b x . (1)ij g ij x ij
Here, m is the population mean, is the additive effect for eachbg
SNP, and is a vector of covariate effects. Recall that the additivebx
genetic effect corresponds to the average change in the pheno-
type when an allele of type a is replaced with an allele of type A
(for details, see the work of Boerwinkle et al.19). To allow for cor-
relation between different observed phenotypes within each fam-
ily, we define the variance-covariance matrix for family i asQi
2 2 2j  j  j if jp ka g eQ p . (2)ijk 2 2{p j  2J j if j( kijk a ijk g
Here, the parameters , , and are variance components20–222 2 2j j ja g e
defined to account for linked major gene effects, background
polygenic effects, and environmental effects, respectively. As
usual, denotes identical-by-descent (IBD) sharing between in-pijk
dividuals j and k at the location of the SNP being tested, and
denotes the kinship coefficient between the same two indi-Jijk
viduals. The model defined in equations (1) and (2) or very similar
models form the basis of many family-based association tests.9,12
These tests perform well when SNP genotypes are available for
all (or nearly all) phenotyped individuals, and, below, we extend
two of these tests to accommodate individuals for whom geno-
types at the SNP being tested are missing. First, we show how
estimates of unobserved genotypes can be obtained. Then, we
show how these estimates can be incorporated into variance-
components–based likelihood-ratio and score tests.
Estimating Unobserved Genotypes
High-throughput SNP genotyping data can be costly and time
consuming to generate. When data of this type are generated only
for a subset of individuals in each family, it is desirable to estimate
genotypes for other individuals in the family, so as to incorporate
all available phenotype information in tests of association. One
way to accomplish this is to estimate a conditional distribution
of the missing genotypes for every individual in the family. In
addition to the observed genotypes, this conditional distribution
will depend on a vector of intermarker recombination fractions,
v, and a vector of allele frequencies for each marker, F. The in-
termarker recombination fractions v can be obtained from one
of the publicly available genetic maps23,24 or can be estimated
from physical maps, by use of the approximation .23,241 cM ≈ 1 Mb
Our software implementation can rapidly calculate maximum-
likelihood allele-frequency estimates for each locus in most small
pedigrees.25
Consider the situation in which (the genotype at markerGijm
m for individual j in family i) is unobserved, and let denoteGi
all the observed genotype data for family i. Let be aPr (G Fv,F)i
function that provides the probability of the observed genotypes
conditional on a specific vector of intermarker recombinationGi
fractions v and allele frequencies F. This function can be calcu-
lated using the Elston-Stewart26 or Lander-Green27 algorithms, or
it can be approximated using Monte-Carlo methods.28,29 Then,
note that
Pr (G ,G p A/AFv,F)i ijmPr (G p A/AFG ,v,F)p ,ijm i Pr (G Fv,F)i
Pr (G ,G p A/aFv,F)i ijmPr (G p A/aFG ,v,F)p , andijm i Pr (G Fv,F)i
Pr (G ,G p a/aFv,F)i ijmPr (G p a/aFG ,v,F)p . (3)ijm i Pr (G Fv,F)i
One approach15 for dealing with unobserved genotypes is to
check whether any of these conditional probabilities exceeds a
predefined threshold (say, 0.99) and then to impute the corre-
sponding genotype. Although this approach would work well in
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Figure 1. Exemplar scoring of expected genotype scores. In each
panel, the first sibling (individual II-1) is marked with an arrow.
In panel A, only the first sibling is genotyped, and no flanking-
marker data are available. In panel B, hypothetical flanking-marker
data are available and can be used to characterize IBD sharing
between the genotyped individual and her siblings. In panel C,
two individuals are genotyped, providing further information.
some settings, it could still result in the discarding of useful in-
formation. Instead of imputing the most likely genotype, we im-
pute the expected genotype score, , which we define asg¯ijm
g¯ p E(g FG ,v,F)ijm ijm i
p 2P(G p A/AFG ,v,F) P(G p A/aFG ,v,F) . (4)ijm i ijm i
As detailed below, whenever a genotype is not observed, this
expected genotype score can be used in place of the observedg¯ijm
genotype . Whatever approach is used to calculate the likeli-gijm
hood of the different genotype configurations, note that all ge-
notype configurations whose likelihoods are evaluated differ by
only one or two genotypes; thus, many portions of the likelihood
calculation can be reused. By use of our implementation of the
Lander-Green algorithm,25,30 these expected genotype scores can
be calculated very rapidly in most small pedigrees (typically, only
a few seconds are required to calculate expected genotype scores
for ∼500,000 markers in a small sibship). The Lander-Green al-
gorithm assumes that the likelihood calculation can be updated
one marker at a time and that its complexity increases exponen-
tially with pedigree size. For larger pedigrees (e.g., those with 115
individuals), we have implemented an Elston-Stewart version of
the approach, complete with genotype elimination.31 The Elston-
Stewart algorithm is designed for pedigrees with no inbreeding
and assumes that the likelihood calculation can be factored by
individual. Its complexity increases exponentially with the num-
ber of markers being analyzed, so that only a subset of the avail-
able flanking markers can be used to estimate each unobserved
genotype (typically, 5–10 flanking markers can be used, depend-
ing on the pattern of missing data in the pedigree). Both imple-
mentations are available with source code from our Web sites
(Ghost and Merlin).
Figure 1 provides an example of how the expected genotype
scores are coded. In figure 1A, only the first sibling is genotyped,
and no genotype information is available for the three siblings.
Thus, the first sibling is assigned a genotype score of 2 (corre-
sponding to two copies of allele A), whereas the other siblings
are assigned identical genotype scores of (where p is the1 p
population frequency of allele A). In figure 1B, information at
flanking markers is available for all individuals, specifying IBD
sharing patterns in the family and resulting in distinct expected
genotype scores for each of the siblings (note that, in this case,
genotypes could only be inferred for the fourth sibling). In figure
1C, genotype information at the candidate marker is available for
one additional sibling, and all genotype scores become integers.
In the situation depicted in figure 1C, it would actually be possible
to impute genotypes for the third and fourth siblings as A/a and
A/A.
Extended Model for Association
To accommodate individuals with missing genotype data, we ex-
tend our model by replacing equation (1) with
¯E(Y )p m b g  b x . (5)ij g ij x ij
In this setting, although the above equality holds, the variance-
components model given in equation (2) is only approximate
(because the variance of each around will be slightlyY E(Y )ij ij
smaller when the genotype score is known and the marker being
tested is associated with the trait than when the genotype score
is estimated). However, we note that (i) simulations suggest our
method appears to perform correctly and (ii) since most geno-
types will have no impact or only a small impact on the trait,
the differences between our approximation and more-accurate
but cumbersome approaches should be slight.
Tests of Association
One natural way to test association is to consider the multivariate
normal likelihood
′ 1n /2 1/2 [yE(y )] Q [yE(y )]i i i i i iLp (2p) FQ F e . i
i
Here, is the number of phenotyped individuals in family i andni
is the determinant of matrix . The likelihood can be max-FQ F Qi i
imized numerically, with respect to the parameter m and the co-
efficients and —which together define the expected phe-b bg x
notype vector for family i, —and the variance componentsE(y )i
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, , and —which together define the variance-covariance ma-2 2 2j j ja g e
trix for family i, . To test for association, we first maximize theQi
likelihood under the null hypothesis with the constraint that
and denote the resulting likelihood as . We then repeatb p 0 Lg 0
the procedure without constraints on the parameters, to obtain
. Then, a likelihood-ratio test (LRT) statistic that is asymptoti-L1
cally distributed as x2 with 1 df can be used to evaluate the evi-
dence of association:
LRTT p 2 lnL  2 lnL .1 0
The LRT statistic above requires that and be maximizedL L0 1
numerically for each SNP, a procedure that can become compu-
tationally prohibitive on a genomewide scale. Maximization of
is required because estimates of depend on the observed2L j0 a
patterns of IBD sharing at each location. When available com-
puting time is limited, an alternative approach is to first fit a
simple variance-components model to the data (with parameters
m, , , and but without parameters and ). This model2 2 2b j j b jx g e g a
provides a vector of fitted values for each family, which we denote
, and an estimate of the variance-covariance matrix for(base)E(y )i
each family, which we denote . Using these two quantities,(base)Qi
we define the score statistic
′ 1 2(base) (base)¯ ¯ g  E(g ) Q y  E(y ){ [ ] [ ] [ ]}i i i i i
iSCORET p ,′ 1(base)¯ ¯ ¯ ¯ g  E(g ) Q g  E(g )[ ] [ ] [ ]i i i i i
i
where is a vector with expected genotype scores for each in-g¯i
dividual in the ith family, calculated conditional on the available
marker data, and is a vector with identical elements that give¯E(g )i
the unconditional expectation of each genotype score. This ex-
pectation is 2p, or twice the frequency of allele A at the SNP being
tested. The value 2p arises from the assumption of Hardy-Wein-
berg equilibrium in the population; before conditioning on ge-
notypes of related individuals, we have probability of observing2p
genotype A/A and probability of observing genotype2p(1 p)
A/a. Thus, for any i and j, we have ¯E(g )p E(g )p 2 Pr (G pij ij ij
. is approxi-2 SCOREA/A)Pr (G p A/a)p 2p  2p(1 p)p 2p Tij
mately distributed as x2 with 1 df. In contrast to the statistic,LRTT
which requires one round of numerical maximization for each
marker, the statistic requires only a single round of nu-SCORET
merical optimization to estimate and . Thus, the(base) (base)Q E(y )i i
statistic should provide a useful and computationally ef-SCORET
ficient screening tool for genomewide studies. In our preliminary
analyses, it allows genomewide association scans in data sets that
include thousands of individuals in modest-sized pedigrees (15
individuals) to be completed within a few hours. It is important
to note that the distribution of will deviate from x2 whenSCORET
is large. In practice, should be used for an initial screen-2 SCOREj Ta
ing phase in genomewide studies, and promising findings should
be reevaluated with the statistic to avoid an excess of false-LRTT
positive results in regions of strong linkage. The number of prom-
ising statistics that can be reevaluated with will depend onLRTT
the available computational resources. We recommend that at
least those statistics selected for further follow-up should be eval-
uated with .LRTT
Simulations
To evaluate the performance of our approach, we simulated dif-
ferent types of pedigrees and patterns of missing genotype data
at the SNP being tested for association. Unless otherwise specified,
we simulated a SNP with a minor-allele frequency (MAF) of 0.30
that explained 5% of the trait variance and simulated background
polygenic effects that accounted for a further 35% of the trait
variability. In addition, we simulated genotype data for a 0.3-cM
grid of 50 equally spaced flanking SNPs, each with two equally
frequent alleles. This should be approximately analogous to using
10,000 SNP markers across the genome to genotype individuals
not selected for high-density scanning. We implemented our sim-
ulation engine within Merlin,25,30 allowing others to easily repro-
duce our results and simulations. To summarize analyses of sim-
ulated data, we report expected LOD scores (ELODs), which were
calculated as the average of the LOD scores estimated after anal-
ysis of each replicate. As usual, LOD scores were defined as
.2x /2 ln (10)
Exemplar Data Set
To examine the performance of our method in a real data set, we
reanalyzed the data of Cheung et al.32 The original analysis of
Cheung et al.32 used genotypes generated by the International
HapMap Consortium1 to search for SNPs that regulate mRNA lev-
els of 27 different transcripts. The analysis focused on individuals
for whom both high-density SNP genotype data and gene-
expression data were available. These individuals form part of
extended 3-generation pedigrees, and measurements of mRNA
levels, as well as limited genotype data, are available for many
additional individuals in the pedigrees.33 Thus, we used our ap-
proach to combine all the available information (i.e., mRNA levels
for 156 individuals, 6,728 SNP genotypes for all 168 individuals,
and 864,360 additional SNP genotypes for each of the 90 indi-
viduals genotyped by the HapMap Consortium).
Results
Type I Error Rates
Before evaluating power for our proposed approach, we
checked type I error rates in a variety of settings, including
different family sizes and subsets of genotyped individu-
als. In each simulated replicate, we tested for association
at a SNP in linkage equilibrium with the QTL but tightly
linked to it (recombination fraction ). Table 1 sum-vp 0
marizes the performance of the method for nuclear fam-
ilies with four offspring each and with different subsets
of genotyped individuals (results were similar for other
family configurations, including nuclear families with dif-
ferent numbers of offspring and a variety of small 3-gen-
eration pedigrees; data not shown). To generate each row
in the table, we examined 100,000 replicates, each with
a simulated QTL explaining 5% of the quantitative-trait
variation and a total trait heritability of 40%. It is clear
from the table that both the proposed LRT and score test
(SCORE) have type I error rates very close to their target
a levels. In fact, when the 1.8 million replicates that were
analyzed to generate table 1 are considered together, we
observed average type I error rates of 0.00008 (LRT) and
0.00009 (SCORE test) at the level. In this com-ap 0.0001
bined set of 1.8 million replicates, type I error rates for
both tests also appeared to be well controlled at more-
stringent significance levels. Specifically, we observed 15
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replicates significant at (vs. 18 expected) and5ap 10
none significant at (vs. 1.8 expected). Marker6ap 10
spacing and allele frequencies did not appear to have a
significant impact on type I error rates for the LRT and
SCORE test statistics.
When varying the genetic model, we observed that the
type I error rate for the SCORE test increased slightly when
the effect of the tightly linked QTL was large (e.g., when
the simulated QTL explained 120% of the trait variance).
This is expected because the SCORE test does not take IBD
sharing into account when modeling the correlation be-
tween relatives. In practice, we recommend that the
SCORE test be used as a computationally efficient screen-
ing tool for genomewide studies and that interesting re-
sults (i.e., those for which the SCORE test P value is !.01
or some other appropriate threshold) be followed up with
the LRT. In our simulations, this two-stage procedure re-
sulted in power and type I error rates equivalent to ap-
plication of the LRT to the entire data set.
Power for Sib-Pair Families
After evaluating type I error rates, we proceeded to eval-
uate the power of our proposed approach in small families
and its efficiency for different subsets of genotyped in-
dividuals. Table 2 shows the expected LOD scores for the
LRT and SCORE statistics when association was evaluated
in a sample of 350 nuclear families, each with two off-
spring. In each row, a different subset of individuals was
genotyped for the marker being tested for association. By
comparison of test statistics calculated using only geno-
typed individuals (table 2, columns 2 and 4) with those
calculated using estimated genotype counts for other in-
dividuals (table 2, columns 3 and 5), it is clear that ge-
notype inference increases power, irrespective of whether
the LRT or SCORE test is used (increases in expected LODs
ranged from ∼15% to ∼32%, depending on the individuals
selected for genotyping when flanking-marker data are
available).
In absolute terms, the most powerful approach is to
genotype all individuals for the SNP being tested, resulting
in an expected LOD of 13.68 (LRT) and power 199% (table
2). However, this is also likely to be the most costly strat-
egy, because it requires the largest genotyping effort. Ge-
notyping the candidate SNP in two parents and one off-
spring reduces the amount of genotyping required by 25%
and results in only a slight decrease in the ELOD, to 13.15
(a 4% decrease from the LRT ELOD), and still retains power
199% (table 2).
Strategies that involve genotyping fewer individuals re-
sult in further losses of power but can be even more cost
effective on a per-genotype basis. For example, genotyping
only one offspring per family results in an ELOD per ge-
notype that is ∼60% higher than when all individuals are
genotyped (ELOD of 0.0159 vs. 0.0098 per genotype). This
means that, given fixed genotyping resources, it usually
will be better to genotype only a few individuals per family
in a large number of families than to genotype a subset
of the available families more extensively. When two in-
dividuals per family are genotyped, the most cost-effective
strategy is to genotype one parent and one offspring per
family (ELOD of 0.014 per genotype). This choice of in-
dividuals provides good information about phases for
three of the four haplotypes segregating in the family, and
allows our method to take advantage of flanking-marker
data to fill in the missing genotypes for the other two
individuals. Other choices, such as genotyping two par-
ents or genotyping two siblings, provide less-accurate
phase information and result in estimates of the missing
genotypes that are less good.
The last two rows of table 2 show that the method is
attractive even when parental data are not available. In
this case, when only one child is genotyped, it is very hard
to infer the genotype of the other child (because the two
will be IBD only 25% of the time). Nevertheless, note that
the ELOD per genotype is 0.0108 when both children are
genotyped but increases to 0.0142 when only one child
is genotyped and our approach is used (an ∼30% increase
in efficiency on a per-genotype basis). Further, it is im-
portant to note that, although the availability of flanking-
marker information clearly improves the performance of
our method, the approach is still valuable when flanking-
marker data are not available. When we repeated the anal-
ysis without flanking-marker data, the ELOD per genotype
decreased to 0.0130 when only one child was genotyped,
but this is still ∼20% higher than the ELOD of 0.0108
when only the observed genotypes are used in the asso-
ciation analysis. Thus, our approach of using expected ge-
notype scores in the analysis can lead to gains in power
even when there is substantial uncertainty about all the
missing genotypes.
Power for Larger Nuclear Families
We next evaluated the performance of our method in
larger nuclear families, each with four offspring (table 3).
In this setting, each genotyped individual provides infor-
mation about a larger number of ungenotyped individu-
als, and the potential efficiency gains are larger. Including
ungenotyped individuals in the analysis resulted in sub-
stantial increases in the expected test statistic (ranging
from ∼15% to ∼60%, depending on the subset of individ-
uals selected for genotyping). In addition, for the ELOD
on a per-genotype basis, the most effective strategy was
again to genotype just one child per family (ELOD per
genotype is 0.0159 in the families with two offspring ex-
amined [table 2] and is 0.0194 in the families with four
offspring examined [table 3]). With a fixed set of 250 fam-
ilies, this strategy provided 36% of the total ELOD for
∼17% (one-sixth) of the genotyping effort. Collecting ge-
notypes for one parent and one offspring per family was
also very efficient (ELOD per genotype of 0.0176), pro-
viding ∼65% of the total ELOD for ∼33% of the genotyp-
ing effort. Finally, note that, when two parents and one
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Table 4. Power for Nuclear Families
with Four Offspring when MAF
at Associated SNP Is 0.05 or 0.5
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
offspring are genotyped, ∼92% of the expected test sta-
tistic can be recovered for 50% of the genotyping effort.
Additional Simulations
We considered a variety of other configurations for sim-
ulated pedigrees, including larger sibships and 3-genera-
tion pedigrees. Table 4 summarizes the results for situa-
tions in which the associated SNP had a lower or higher
MAF (0.05 or 0.50, respectively). The results are in good
agreement with the results in table 3, showing that the
most-effective genotyping strategies are to examine one
offspring (if only one individual per family is genotyped
at a high density), one parent and one offspring (two in-
dividuals per family), or both parents and one offspring
(three individuals per family). In all settings we examined,
incorporation of phenotypes of ungenotyped individuals
in the analysis increased the power and efficiency (on a
per-genotype basis). As expected, power gains were largest
in large sibships or 3-generation pedigrees. Nevertheless,
even when only a few ungenotyped relatives were avail-
able, we found that estimating the missing genotypes pro-
vided meaningful increases in power (tables 2 and 3). We
also observed that, on average, the LRT statistic was
slightly more powerful than the SCORE statistic and
that this advantage appeared to be enhanced in larger
pedigrees.
Analysis of Exemplar Data Set
As a complement to the simulation studies presented
above, we reanalyzed publicly available data for 27 gene-
expression traits.32,33 The data consist of gene-expression
measurements for 156 individuals in 20 3-generation
CEPH pedigrees, each with 12–17 individuals. Genotypes
for 864,360 SNPs were generated for a subset of 90 indi-
viduals in these families in phase I of the International
HapMap Project1 (all individuals genotyped by the Hap-
Map Consortium were in the grandparental or parental
generation). Genotypes for 6,728 SNPs for the complete
families, including 168 individuals, were also genotyped
previously by the SNP Consortium.23 There are 12 indi-
viduals with genotype data but no gene-expression data.
In their original analysis, Cheung et al.32 focused on a
subset of unrelated individuals from the grandparental
generation to evaluate the impact of each SNP on gene
expression, using a simple linear regression. We repeated
their analysis, using our approach, first without inference
of any missing genotypes (i.e., using only the observed
genotypes for individuals in the parental and grandpar-
ental generations) and then with use of expected genotype
scores for all individuals. To reduce the impact of outliers
and nonnormal trait distributions on our analyses, we
used quantile normalization to convert each phenotype
to approximate normality.34 For computational conve-
nience, we used our implementation of the Elston-Stewart
algorithm to infer missing genotypes by use of eight flank-
ing markers. We decided on eight flanking markers to bal-
ance computational constraints for our implementation
of the Elston-Stewart algorithm (whose complexity in-
creases exponentially with the number of markers) and
accuracy of estimated allele counts. By use of exactly the
same 3-generation pedigree structure as used by Cheung
et al.,32 our simulations showed that eight SNPs with high
heterozygosity extracted nearly the same information as
did an infinitely dense map of fully informative markers
(such that a map of fully informative markers would
change test statistics by !3%; authors’ unpublished data).
Estimation of genotype counts for all individuals and cal-
culation of the statistic at each SNP for all 27 traitsSCORET
took !23 h by use of a 2.33-GHz Pentium Workstation.
The analyses were conducted one chromosome at a time
and required !256 Mb of RAM.
Figure 2 summarizes our results for the analysis of
CTBP1 expression level, 1 of the 27 phenotypes analyzed.
The CTBP1 gene maps to chromosome 4. Figure 2A shows
results for the simplest analysis strategy, which focuses on
a subset of 60 unrelated individuals and uses ordinary
least-squares regression. This analysis ignores much of the
available data and does not provide a clear association
signal. Figure 2B shows the use of observed genotypes for
the 90 individuals genotyped by the HapMap Consortium1
and shows a peak of association on chromosome 4 at SNP
rs11247978, which is within 18.8 kb of the CTBP1 gene.
The peak corresponds to a P value of . Figure71.8# 10
2C provides results for our preferred approach, which uses
the expected genotype scores to extract information from
relatives of genotyped individuals who themselves may
not have been genotyped for the marker of interest. This
analysis considers a total of 156 individuals and again
provides a clear signal of association on chromosome 4 at
SNP rs11247978, with a P value of .92.6# 10
Figure 2D, which presents a Q-Q plot for the statistics
in figure 2C, shows that, overall, the SCORE P values are
distributed uniformly between 0 and 1. In figure 2E, the
log Q–log Q plot for the statistics in figure 2C focuses
attention on the tail of the distribution. There are some
clear outliers, with 25 P values . Among these, 225! 10
correspond to the cis association signal and map within
100 kb of the CTBP1 gene.
Thus, our proposed association test appears to behave
correctly in this real data set. The top associated SNP
mapped in cis of the CTBP1 gene in genome scans with
use of the SCORE statistic and either the expected geno-
type scores (fig. 2C) or all available genotypes (fig. 2B) but
not when analysis was restricted to a subset of unrelated
individuals (fig. 2A). Also note that the contrast between
922 The American Journal of Human Genetics Volume 81 November 2007 www.ajhg.org
Figure 2. Genome scan for CTBP1 expression levels. The gene maps to the beginning of chromosome 4. A, Genome scan using 60
unrelated individuals only. B, Genome scan using all 90 individuals genotyped by the HapMap Consortium. C, Genome scan that augmented
the observed genotypes with expected genotype scores for other individuals, resulting in a total sample size of 156 individuals. All
analysis were performed using the computationally efficient SCORE statistic. D, Q-Q plot. E, log Q–log Q plot. The plots show that the
statistic is behaving adequately.
the strength of the cis signal and background noise is clear-
est in figure 2C, where expected genotypes are used to
extract information from individuals with missing geno-
type data.
A similar pattern was observed for the other traits. Table
5 lists the SNP showing the most significant association
with each trait (transcript expression level) when analyses
were performed using only a subset of 60 unrelated in-
dividuals and ordinary least-squares regression (columns
3–5), when analyses were performed using genotypes for
90 individuals genotyped by the HapMap Consortium for
whom gene expression data were available (columns 6–
8), and when analyses were performed using all available
data by incorporating expected genotype scores into the
analysis (columns 9–12). The top SNP association for each
transcript was selected by analyzing all available SNPs by
use of the SCORE test. P values and variance explained by
the top SNP (per trait) were then estimated using the full
likelihood model. Since we have scanned the whole ge-
nome for association, it is extremely unlikely that the peak
of association would occur in cis purely by chance, and
we expect that the number of cis signals detected is a rea-
sonable proxy for the relative power of the different
analyses.
The evidence of association reaches genomewide sig-
nificance (nominal , by use of an overall8Pp 5.7# 10
and a Bonferroni correction) for 15 of the 27ap 0.05
expression levels by use of our approach, for 12 expression
levels by use of only observed genotypes, and for 10 ex-
pression levels by use of genotypes of unrelated individ-
uals only. All significant genomewide associations iden-
tified were in cis of the putatively regulated gene. Each
approach identified an additional 2–4 expression levels for
which the top associated SNP mapped in cis of the pu-
tatively regulated probe but did not reach genomewide
significance. One curious finding in our results is the as-
sociation between PSPHL transcript levels and rs2419485,
for which the cis association appears to be quite distant
from the gene. However, the PSPHL gene and rs2419485
actually map to opposite sides of the centromere for chro-
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Table 5. Summary of Reanalysis of Data from Cheung et al.,32 with Different Analytical Strategies
Transcript Chromosome
Strategy Using Founder
Genotypes Only
Strategy Using All
Observed Genotypes Strategy Using Imputed Genotype Scores
Top SNP
Distance
or Positiona P Top SNP
Distance
or Positiona P Top SNP
Distance
or Positiona P H2
LRAP 5 rs10051637 25.8 kb !1020 rs1981846 10.6 kb !1019 rs27307 84.8 kb !1028 73.1
POMZP3 7 rs2005354 In transcript !1016 rs2005354 In transcript !1014 rs2005354 In transcript !1022 70.6
IRF5 7 rs7789423 31.1 kb !1010 rs6969930 40.2 kb !108 rs10239340 79.0 kb !1017 47.4
HSD17B12 11 rs4755741 74.9 kb !108 rs4755741 74.9 kb !1010 rs1878851 In transcript !1016 42.2
AA827892 20 rs1739646 11.6 kb !108 rs1739646 11.6 kb !1011 rs1739646 11.6 kb !1016 45.1
RPS26 12 rs2271194 39.7 kb !1010 rs2271194 39.7 kb !107 rs2271194 39.7 kb !1014 50.6
HLA-DRB2 6 rs9275141 16.5 kb !109 rs9275141 16.5 kb !108 rs9275141 16.5 kb !1014 48.2
PSPHL 7 rs2419485 9.0 Mbb !1013 rs2419485 9.0 Mbb !109 rs2419485 9.0 Mbb !1014 60.5
CPNE1 20 rs6060535 In transcript !107 rs6058296 16.4 kb !109 rs6060578 63.8 kb !1013 38.6
CSTB 21 rs880987 28.2 kb !1010 rs2276246 14.6 kb !109 rs2838393 37.0 kb !1012 32.7
CTSH 15 rs1369324 2.4 kb !106 rs1036938 .2 kb !1011 rs1369324 2.4 kb !1010 30.6
PPAT 4 rs2161041 Trans, chr 3 !106 rs2139512 25.2 kb !106 rs2139512 In transcript !1010 37.0
CTBP1 4 rs11246311 Trans, chr 11 !105 rs11247978 18.8 kb !106 rs11247978 18.8 kb !109 30.3
CHI3L2 1 rs755467 In transcript !106 rs1325284 In transcript !107 rs2477578 In transcript !109 33.4
IL16 15 rs6698333 Trans, chr 1 !105 rs731908 Trans, chr 13 !106 rs731908 Trans, chr 13 !108 22.6
ZNF85 19 rs1869051 Trans, chr 2 !105 rs10454111 In transcript !106 rs11672610 .8 kb !108 25.8
DDX17 22 rs7004029 Trans, chr 8 !105 rs10401935 Trans, chr 19 !106 rs3756726 Trans, chr 5 !106 20.7
GSTM2 1 rs1005932 Trans, chr 2 !105 rs1074334 Trans, chr 14 !105 rs412543 12.0 kb !106 23.4
TCEA1 8 rs1960350 Trans, chr 11 !106 rs1046995 Trans, chr 1 !106 rs952194 105.2 kb !106 22.2
GSTM1 1 rs3118590 Trans, chr 9 !105 rs9428368 113.6 Mbc !106 rs412543 .5 kb !105 21.6
VAMP8 2 rs1835307 Trans, chr 1 !106 rs254677 Trans, chr 5 !106 rs3755015 40.7 kb !105 20.8
SMARCB1 22 rs3861946 Trans, chr 1 !105 rs1517492 Trans, chr 2 !105 rs4497390 Trans, chr 11 !105 11.9
ICAP-1A 2 rs4713169 Trans, chr 6 !105 rs7739016 Trans, chr 6 !106 rs10501853 Trans, chr 11 !105 18.4
S100A13 1 rs9586149 Trans, chr 13 !106 rs1502430 Trans, chr 16 !104 rs2571343 Trans, chr 12 !105 16.1
TM7SF3 12 rs7934888 Trans, chr 11 !106 rs7934888 Trans, chr 11 !105 rs7637623 Trans, chr 3 !105 25.2
EIF3S8 16 rs2973361 Trans, chr 5 !106 rs878724 Trans, chr 9 !104 rs12552044 Trans, chr 9 !105 18.1
CGI-96 22 rs1519568 Trans, chr 3 !106 rs6765660 Trans, chr 3 !105 rs1880693 Trans, chr 11 !104 20.0
NOTE.—The three columns under the first strategy show the marker with strongest association, its position relative to the transcript, and the
associated P value when unrelated individuals are selected from each family (the grandparents, for a total of 60 individuals) and are analyzed using
linear regression. The next three columns show the marker with strongest association, its position relative to the transcript, and the associated P
value when all individuals genotyped by the HapMap Consortium are included in analysis (90 individuals in the grandparental and parental generations).
In this instance, our proposed score test but no estimates of missing genotypes were used to perform association analyses. The last four columns
summarize the results for our recommended strategy, incorporating estimated genotypes for all individuals. Our score test was used to evaluate all
SNPs, and a follow-up analysis of the SNP showing the strongest association was performed using the LRT (which was used to produce the reported
P value and the proportion of variance explained by association with each SNP, H2). chr p Chromosome.
a Unless stated otherwise, the SNPs map to the same chromosome as the transcript.
b The rs2419485 SNP and the PSPHL transcript are separated by the centromere of chromosome 7. Other SNPs closer to the transcript are in strong
LD with rs2419485 and also show association with expression levels.
c This cis association result is probably a false-positive result.
mosome 7 and are in a region of very extensive linkage
disequilibrium. In fact, rs2419485 is in strong linkage dis-
equilibrium with SNPs that are much closer to PSPHL and
could very well be a surrogate for them.
In addition to the 15 cis associations reported by
Cheung et al.,31 we found 4 cis associations in our study,
for phenotypes CTBP1, ZNF85, TCEA1, and VAMP8. In
total, among the 19 peak cis-associated SNPs identified
using our approach, 4 map within the gene, and all but
one (PSPHL) map to a region within 106 kb of the gene.
We expect that most of the identified cis associations are
real, in that they reflect an association between specific
SNPs and the strength of the mRNA hybridization signal.
Thus, we interpret the fact that our proposed approach
identified more cis associations as evidence that it provides
a more powerful analytical strategy. In fact, three of the
four new cis signals we report (CTBP1, ZNF85, and VAMP8)
were replicated in an independent set of ∼400 individuals
examined with a different expression array and genotyped
with a different technology (all P values ).359! 10
We also compared the findings from the genome scan
for the 27 phenotypes in table 5 with those from the link-
age scans by Morley et al.32 Morley et al. report that all
27 phenotypes show evidence of cis linkage. As noted
above, for 19 of the phenotypes, we identified evidence
of cis association, which is consistent with the linkage
signals. For eight others, we did not uncover evidence of
cis association, despite the evidence of linkage reported
by Morley et al.32 In these cases, the linkage signal could
be artifactual, the regulatory alleles may not be in strong
disequilibrium with the phase I HapMap SNPs examined,
or there may be multiple causal alleles involved—a setting
that might require haplotype tests for successful associa-
tion analysis.
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Discussion
We describe two family-based association tests. One relies
on computationally intensive maximum-likelihood esti-
mation. The other uses a computationally efficient score
test to rapidly evaluate evidence of association at hun-
dreds of thousands of markers. Although our tests can be
used for samples in which all individuals are genotyped
at all markers of interest, both of our proposed family-
based association tests can accommodate phenotype data
for individuals for whom genotype data are not available.
Whenever one or more relatives of these individuals are
genotyped at the marker of interest, expected genotype
counts are calculated for the ungenotyped individual and
are used to improve the power of subsequent association
analysis. Our approach allows family samples collected for
linkage studies or for studies of parent-of-origin effects to
be used effectively in genomewide association studies. For
the same number of genotyped individuals, genotyping a
small number of individuals in each family and estimating
the genotypes for their relatives provides more power than
does simply examining the unrelated individuals. Thus,
the approach described here is especially attractive in sit-
uations where the number of individuals to be examined
is limited by cost considerations, such as when new tech-
nologies are evaluated (such as higher-density SNP chips
or genome resequencing chips).
Consistent with previous results,15,17 our results show
that estimating genotypes for phenotyped individuals
with missing genotype data can produce substantial in-
creases in power. We also show that, in the analysis of
gene-expression data, incorporation of estimated geno-
types for phenotyped individuals with incomplete geno-
type data resulted in more findings of cis associations. The
quality of the estimated genotypes will depend on the
availability of flanking-marker data. In many cases, these
data will be readily available because of a previous linkage
scan. Even when flanking-marker data are not available,
phenotypes of related individuals can be incorporated in
the analysis because our method uses expected genotype
counts, which can be estimated even when there is un-
certainty about the identity of the missing genotypes. Our
use of expected genotype counts allows for great flexibility
in the choice of which individuals to genotype in each
family.
Our method does not provide a built-in safeguard
against population stratification (in contrast to the trans-
mission/disequilibrium test7 and related methods). We de-
cided not to include this built-in safeguard, so as to in-
crease power. Our approach already has been applied
successfully to study quantitative traits related to complex
disease in humans.35–37 In practice, we recommend that
the distribution of test statistics across the genome be in-
spected—if a deviation from the null is suspected, the
analysis could be repeated, incorporating estimates of in-
dividual ancestry14,18 as covariates in the analysis, or the
test statistics could be adjusted using a suitable genomic-
control method.13 Naturally, after covariates are included
and the analysis is repeated, the distribution of statistics
across the genome should be inspected again. We expect
that use of individual ancestry as a covariate will be an
appropriate strategy for avoiding the effects of population
stratification at most markers but may be insufficient for
markers at a few loci (such as the human leukocyte antigen
locus [HLA]) that show very strong differentiation even
among closely related populations and ethnic groups. In
these cases, it may be prudent to rely on traditional trans-
mission/disequilibrium–based methods whose false-posi-
tive error rates are insensitive to any form of population
structure.
Our simulation results provide guidance to investigators
who plan to genotype a subset of individuals in an existing
family collection. If only one individual can be genotyped
in each nuclear family, our results show that genotyping
one child provides the most power. If two individuals are
to be genotyped per nuclear family, genotyping one parent
and one child will provide the most power on a per-
genotype basis. With three genotyped individuals per fam-
ily, the best choice is to genotype two parents and one
child. We recognize that other considerations are impor-
tant in deciding whom to genotype. For example, some-
times it may be desirable to genotype two parents (but no
offspring), to facilitate haplotype analyses that rely on un-
related individuals. In other cases, the choice of which
individuals to genotype may be guided by the avail-
ability of DNA samples. In yet other cases, it may be
desirable to use prior evidence of linkage to guide the
choice of which individuals to genotype.38 Our software
implementation is general and will use arbitrary sets of
genotyped individuals to estimate genotypes for their
relatives.
To estimate missing genotypes, our association test relies
on standard pedigree likelihood calculations, which we
implemented using the Lander-Green27 or Elston-Stewart26
algorithm. Our implementations naturally take advantage
of computational enhancements to these algorithms—for
example, our Lander-Green implementation uses the
method of Idury-Elston to speed up multipoint calcula-
tions,39 the method of Abecasis et al.30 to take advantage
of recurring terms in likelihood calculations, and the
methods of Abecasis and Wigginton25 to model linkage
disequilibrium within clusters of tightly linked markers.
Since the key calculations involved in implementing
our method rely on existing algorithms, we were also able
to implement our method for the X chromosome with
minimal effort. Our X-chromosome implementation
models kinship coefficients on the X chromosome as de-
scribed elsewhere34 and assumes that average phenotypic
values for hemizygous males are the same as for homo-
zygous females.
It has been proposed that appropriately designed family-
based association tests can be used to perform screening
and replication analysis using one set of families.40 If our
method is used to evaluate the evidence of association
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after a subset of individuals is genotyped (stage 1), inves-
tigators may consider genotyping the remainder of the
individuals to follow up promising findings (stage 2). If a
replication analysis is desired, estimated genotype counts
from the first stage of the analysis (estimated using stage
1 genotype data only) can be included as covariates when
the complete genotype data are analyzed. In this way, it
will be possible to use a subset of individuals to screen for
association and then to replicate the finding by genotyp-
ing additional individuals from the same family sample.
It is important to note that a combined analysis of the
stage 1 and stage 2 data, with a stringent significance
threshold, often will provide more power than simply us-
ing the stage 2 data to replicate stage 1 findings.41
In the results presented here, we have focused on im-
puting genotypes for all individuals in each family when
a subset of individuals is genotyped at the marker of in-
terest. Whenever possible, we relied on flanking-marker
data and the Lander-Green or Elston-Stewart algorithm to
identify shared segments of chromosome among the in-
dividuals in each family and thus to impute the missing
genotypes. In principle, genotype inference can be ex-
tended to the population level—a setting in which shared
segments of chromosome are likely to be much shorter
but should still exist.42 For example, our implementation
allows genotype scores to be estimated for markers that
are completely ungenotyped whenever these markers are
in linkage disequilibrium with nearby typed markers and
when estimates of population haplotype frequencies are
provided to describe the relationship between the unge-
notyped markers and other nearby markers. In the current
implementation, this imputation of ungenotyped markers
relies on a cluster-based linkage-disequilibrium model de-
scribed elsewhere.25
It is also important to note that, although we designed
our approach to use expected genotype scores (so that we
deal with uncertainty in missing genotypes in a manner
that is somewhat similar to the approach used by Zaykin
et al.43 to deal with uncertain haplotype phase in case-
control association tests), it should, in theory, be possible
to implement a full likelihood-based approach that inte-
grates over the joint distribution of missing genotypes for
each family and estimates genetic model parameters si-
multaneously. Although we considered it, we decided that
this full likelihood approach would be cumbersome when
used for the analysis of whole-genome scans, particularly
when a polygenic component is also included in the
model to explain residual resemblance between relatives.
For discrete traits, the LAMP program16,44 integrates over
all missing genotypes in each family jointly to estimate
genetic model parameters and provides an alternative to
our approach.
Computer programs implementing the approaches
described here are available at our Web sites (Ghost and
Merlin). We hope they will be helpful for investigators
planning to perform quantitative-trait genomewide as-
sociation studies of existing family samples.
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